316 related articles for article (PubMed ID: 11713797)
1. Oligonucleotides as inhibitors of human immunodeficiency virus.
Field AK
Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Yamamoto N; Takaku H
FEBS Lett; 1999 Jul; 456(1):186-90. PubMed ID: 10452555
[TBL] [Abstract][Full Text] [Related]
4. Sense antisense nonantisense. Can these novel antivirals knock HIV senseless?
Chang HE; Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):11-8. PubMed ID: 11362229
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
Hiratou T; Tsukahara S; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1997; (37):221-2. PubMed ID: 9586079
[TBL] [Abstract][Full Text] [Related]
6. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 integrase and RNase H activities as therapeutic targets.
Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
[TBL] [Abstract][Full Text] [Related]
8. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Agrawal S; Tang JY
Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
[No Abstract] [Full Text] [Related]
9. Technology evaluation: GEM-92, Hybridon Inc.
Zheng R
Curr Opin Mol Ther; 1999 Aug; 1(4):521-3. PubMed ID: 11713769
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
[TBL] [Abstract][Full Text] [Related]
11. The daunting challenge of keeping HIV suppressed.
Cohen J
Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
[No Abstract] [Full Text] [Related]
12. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
13. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
Gu SX; Xue P; Ju XL; Zhu YY
Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
[TBL] [Abstract][Full Text] [Related]
14. Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase.
Patel RV; Park SW
Bioorg Med Chem; 2015 Sep; 23(17):5247-63. PubMed ID: 26116177
[TBL] [Abstract][Full Text] [Related]
15. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
[TBL] [Abstract][Full Text] [Related]
16. Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical development.
Holmlund JT; Monia BP; Kwoh TJ; Dorr FA
Curr Opin Mol Ther; 1999 Jun; 1(3):372-85. PubMed ID: 11713802
[TBL] [Abstract][Full Text] [Related]
17. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
de Soultrait VR; Desjobert C; Tarrago-Litvak L
Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
[TBL] [Abstract][Full Text] [Related]
18. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
Witvrouw M; Debyser Z
Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
[TBL] [Abstract][Full Text] [Related]
19. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
20. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
